CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows used in operating activities:
Net loss	$ (6,635,187)	$ (5,626,925)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	98,363	28,775
Stock based compensation	522,234	629,207
Accretion of right-of-use lease asset	9,717	(1,723)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(342,641)	153,775
Accounts receivable	17,116	91,880
Deposits	(21,146)
Accounts payable and other current liabilities	(443,239)	278,663
Deferred revenue	114,849	(100,000)
Due to related parties	11,855	20,039
Net cash used in operating activities	(6,668,079)	(4,526,309)
Cash flows used in investing activities:
Purchases of property and equipment	(136,795)	(54,630)
Net cash used in investing activities	(136,795)	(54,630)
Cash flows provided by financing activities:
Proceeds from the issuance of common stock, net	17,456,092	7,260,869
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units and net stock option expense	(77,477)	(106,391)
Net cash provided by financing activities	17,378,615	7,154,478
Net increase in cash and restricted cash	10,573,741	2,573,539
Cash and restricted cash at beginning of period	9,908,301	9,604,780
Cash and restricted cash at end of period	20,482,042	12,178,319
Supplemental disclosures of non-cash investing and financing activities:
Issuance of common stock under cashless warrant exercises	676	0
Par value of shares issued for vested restricted stock units and net stock option exercise	33	71
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:
Cash and cash equivalents	20,394,536	12,131,593
Restricted cash	87,506	46,726
Cash and restricted cash	$ 20,482,042	$ 12,178,319